Document Detail

Long-term efficacy and safety of drug-eluting stent implantation for patients with multiple coronary chronic total occlusions.
MedLine Citation:
PMID:  20497665     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Data on the efficacy and safety of drug-eluting stent (DES) for treatment of multiple coronary chronic total occlusion (CTO) lesions are scanty. The aim of the present study was to compare the long-term outcomes of DES versus bare metal stent (BMS) implantation for multiple coronary CTO lesions. METHODS: We analyzed 188 patients who underwent coronary stenting for at least two de novo CTO lesions in our center from November 2000 to November 2006. Among them, 118 patients (62.8%) received DES and 70 patients (37.2%) received BMS implantation after the recanalization for CTO lesions. All patients were followed up for up to 5 years for the occurrence of major adverse cardiac events (MACE). Long-term survival rates were estimated with the Kaplan-Meier method. RESULTS: There were no significant differences in baseline clinical characteristics and procedural success rate between DES group and BMS group. Compared with the BMS group, the DES group showed a significantly higher rate of long CTO (> or = 15 mm) (62.0% vs. 50.6%, P = 0.023). The number of stents per lesion (1.39 +/- 0.71 vs. 1.17 +/- 0.66, P = 0.007) and the mean length of stents in the DES group were also higher than those in the BMS group ((40.8 +/- 11.4) mm vs. (23.4 +/- 8.7) mm, P < 0.001). But the mean diameter of stents in the DES group was smaller than that in the BMS group ((3.1 +/- 0.2) mm vs. (3.3 +/- 0.5) mm, P < 0.001). Average follow-up time was 4.8 +/- 0.7 (1.5 - 5.0) years in the BMS group and 4.3 +/- 0.5 (1.3 - 5.0) years in the DES group. Both the 5-year cumulative survival rates and the target vessel revascularization (TVR)-free survival rates of the DES group were significantly higher than those in the BMS group (83.1% vs. 72.9%, Log-rank P = 0.044; 77.1% vs. 62.9%, Log-rank P = 0.009). The cumulative MACE-free survival rates in the DES group were significantly higher than those in the BMS group (71.2% vs. 51.4%, Log-rank P = 0.001). Multivariable Cox regression analysis demonstrated that DES implantation for multiple CTO lesions could significantly reduce the long-term MACE risk after percutaneous coronary intervention (PCI) (HR: 0.436; 95%CI 0.327 - 0.665, P < 0.001). Age over 65 years (HR: 2.018; 95%CI 1.491 - 3.127, P < 0.001) and left ventricular ejection fraction < 50% (HR: 1.494; 95%CI 1.125 - 2.376, P < 0.001) were identified as the independent predictors of long-term MACE. CONCLUSION: This study demonstrates the long-term (up to 5 years) efficacy and safety of DES for treatment of multiple coronary CTO lesions, and its superiority compared to BMS in reducing the rates of TVR and MACE.
Jian Zhang; Ya-Ling Han; Yi Li; Shou-Li Wang; Quan-Min Jing; Xiao-Zeng Wang; Ying-Yan Ma; Bo Luan; Geng Wang; Bin Wang
Related Documents :
11324805 - Comparison of ticlopidine and cilostazol for the prevention of restenosis after percuta...
16338255 - Benefit of clopidogrel according to timing of percutaneous coronary intervention in pat...
18536865 - Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-co...
24884935 - Tandem keyhole foraminotomy in the treatment of cervical radiculopathy: retrospective r...
16041525 - Pilomatricoma in childhood: a retrospective study from three european paediatric centres.
21205325 - A polypill for primary prevention of cardiovascular disease: a feasibility study of the...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Chinese medical journal     Volume:  123     ISSN:  0366-6999     ISO Abbreviation:  Chin. Med. J.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-05-25     Completed Date:  2010-09-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513795     Medline TA:  Chin Med J (Engl)     Country:  China    
Other Details:
Languages:  eng     Pagination:  789-93     Citation Subset:  IM    
Department of Cardiology, Shenyang Northern Hospital, Shenyang, Liaoning 110016, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary / adverse effects
Coronary Occlusion / mortality,  therapy*
Coronary Thrombosis / chemically induced,  mortality
Drug-Eluting Stents / adverse effects*
Follow-Up Studies
Kaplan-Meiers Estimate
Middle Aged
Proportional Hazards Models
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Absence of gender disparity in short-term clinical outcomes in patients with acute ST-segment elevat...
Next Document:  Clinical outcome after management of unprotected left main in-stent restenosis after bare metal or d...